CAR reports first quarter net profit of $1.41 billion

May 15, 2025

Carreras Ltd (CAR)
Unaudited Financials for the First Quarter Ended March 31, 2025:

Carreras Ltd (CAR) reported a 63% increase in operating revenue for the first quarter ended March 31, 2025, totaling $4.40 billion compared to $2.71 billion in the corresponding three months of the previous year.

Cost of goods sold amounted to $1.80 billion (2024: $1.31 billion), representing a 37% year-over-year increase. Consequently, gross operating profit rose by 86% to $2.61 billion, compared to $1.40 billion for the first quarter ended March 31, 2024.

Other operating income increased by 83% to $110.43 million (2024: $60.33 million), while administrative, distribution, and marketing expenses rose by 14%, from $687.83 million in 2024 to $783.06 million for the three months.

Profit before income tax for the first quarter ended March 31, 2025, amounted to $1.90 billion, a 148% increase relative to the $769.48 million reported in 2024.

Income tax for the three months increased by 145% to $492.35 million (2024: $201.00 million). Net profit for the period amounted to $1.41 billion, a 148% increase from the $568.48 million reported in 2024.

Total comprehensive income for the three months increased by 148% to $1.41 billion (2024: $568.48 million).

Consequently, earnings per share (EPS) for the three months amounted to $0.29 (2024: $0.12). The twelve-month trailing EPS was $0.82, and the number of shares used in these calculations was 4,854,400,000. Notably, CAR’s stock price closed the trading period on May 15, 2025, at $16.10, with a corresponding P/E ratio of 19.57x.

Balance Sheet Highlights

The company’s assets totaled $9.93 billion (2024: $6.89 billion). This increase in total assets was attributable to cash and cash equivalents, which amounted to $4.57 billion (2024: $2.97 billion).

Shareholders’ equity stood at $2.55 billion (2024: $1.82 billion), representing a book value per share of $0.53 (2024: $0.38).

 

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_609342323
March 25, 2026   Sagicor Group Jamaica Limited (SJ) has declared a dividend of $0.89 per stock unit payable on May 6, 2026, to stockholders…
shutterstock_148562033
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that a senior officer purchased 276,992 PJAM shares on March 24, 2026. &…
shutterstock_453968572
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that on March 24, 2026, three Directors were issued a total of 50,634 PJAM sh…
shutterstock_148562033
March 25, 2026   Supreme Ventures Limited (SVL) has advised that on March 17, 2026, a Director purchased 319,424 SVL shares and a related e…
shutterstock_148562033
March 25, 2026   IronRock Insurance Company Limited (ROC) has advised that connected parties sold a total of 70,939 ROC shares during the p…
shutterstock_453968572
March 25, 2026 United States: US Import Prices Jumped by the Most Since 2022 Ahead of War   The cost of imports into the US jumped in Febr…
shutterstock_537598660
March 24, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the first quarter ended January 31, 2026: Indies Pharma Jama…
shutterstock_609342323
March 24, 2026   Indies Pharma Jamaica Limited (INDIES) has declared an interim dividend of $0.135 per stock unit payable on April 30, 2026…